Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696) (Xpect)
This study has been completed.
Study NCT00778999 Information provided by Merck Sharp & Dohme Corp.
First Received on October 23, 2008. Last Updated on May 6, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Genital Diseases, Female
Genital Diseases, Male
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Contraceptive Agents, Female
Contraceptives, Oral, Synthetic
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Reproductive Control Agents
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers